Yilmaz, B. Et Al. 2010. Metformin regresses endometriotic implants in rats by improving implant levels of superoxide dismutase, vascular endothelial growth factor, tissue inhibitor of metalloproteinase-2, and matrix metalloproteinase-9. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY , vol.202, no.4 .

Yilmaz, B., Sucak, A., Kilic, S., Aksakal, O., AKSOY, Y., Lortlar, N., ... SÜT, N.(2010). Metformin regresses endometriotic implants in rats by improving implant levels of superoxide dismutase, vascular endothelial growth factor, tissue inhibitor of metalloproteinase-2, and matrix metalloproteinase-9. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY , vol.202, no.4.

Yilmaz, Bulent Et Al. "Metformin regresses endometriotic implants in rats by improving implant levels of superoxide dismutase, vascular endothelial growth factor, tissue inhibitor of metalloproteinase-2, and matrix metalloproteinase-9," AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY , vol.202, no.4, 2010

Yilmaz, Bulent Et Al. "Metformin regresses endometriotic implants in rats by improving implant levels of superoxide dismutase, vascular endothelial growth factor, tissue inhibitor of metalloproteinase-2, and matrix metalloproteinase-9." AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY , vol.202, no.4, 2010

Yilmaz, B. Et Al. (2010) . "Metformin regresses endometriotic implants in rats by improving implant levels of superoxide dismutase, vascular endothelial growth factor, tissue inhibitor of metalloproteinase-2, and matrix metalloproteinase-9." AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY , vol.202, no.4.

@article{article, author={Bulent Yilmaz Et Al. }, title={Metformin regresses endometriotic implants in rats by improving implant levels of superoxide dismutase, vascular endothelial growth factor, tissue inhibitor of metalloproteinase-2, and matrix metalloproteinase-9}, journal={AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY}, year=2010}